Emergence of Madariaga virus as a cause of acute febrile illness in children, Haiti, 2015-2016.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
01 2019
Historique:
received: 07 08 2018
accepted: 03 11 2018
entrez: 11 1 2019
pubmed: 11 1 2019
medline: 15 2 2019
Statut: epublish

Résumé

Madariaga virus (MADV), also known as South American eastern equine encephalitis virus, has been identified in animals and humans in South and Central America, but not previously in Hispaniola or the northern Caribbean. MADV was isolated from virus cultures of plasma from an 8-year-old child in a school cohort in the Gressier/Leogane region of Haiti, who was seen in April, 2015, with acute febrile illness (AFI). The virus was subsequently cultured from an additional seven AFI case patients from this same cohort in February, April, and May 2016. Symptoms most closely resembled those seen with confirmed dengue virus infection. Sequence data were available for four isolates: all were within the same clade, with phylogenetic and molecular clock data suggesting recent introduction of the virus into Haiti from Panama sometime in the period from October 2012-January 2015. Our data document the movement of MADV into Haiti, and raise questions about the potential for further spread in the Caribbean or North America.

Identifiants

pubmed: 30629592
doi: 10.1371/journal.pntd.0006972
pii: PNTD-D-18-01210
pmc: PMC6328082
doi:

Substances chimiques

Antibodies, Viral 0
RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0006972

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI126357
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
Syst Biol. 2011 Mar;60(2):150-60
pubmed: 21187451
Emerg Infect Dis. 2008 Aug;14(8):1232-9
pubmed: 18680646
Am J Trop Med Hyg. 1980 Jan;29(1):133-40
pubmed: 7352621
PLoS Negl Trop Dis. 2016 Apr 21;10(4):e0004554
pubmed: 27101567
J Med Entomol. 2008 Jul;45(4):720-5
pubmed: 18714873
Am J Trop Med Hyg. 2007 Feb;76(2):293-8
pubmed: 17297038
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Am J Trop Med Hyg. 2018 Jun;98(6):1798-1804
pubmed: 29737271
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Sci Rep. 2017 Aug 18;7(1):8718
pubmed: 28821712
PLoS Negl Trop Dis. 2016 Apr 25;10(4):e0004687
pubmed: 27111294
PLoS Negl Trop Dis. 2018 May 31;12(5):e0006505
pubmed: 29851952
N Engl J Med. 2013 Aug 22;369(8):732-44
pubmed: 23964935
Emerg Infect Dis. 2007 May;13(5):764-7
pubmed: 17553261
J Hered. 2017 Jun 1;108(4):431-437
pubmed: 28379490
Clin Infect Dis. 2018 Aug 1;67(4):619-621
pubmed: 29718127
Am J Trop Med Hyg. 2015 Jun;92(6):1130-2
pubmed: 25870420
Nucleic Acids Res. 2005 Apr 07;33(6):e65
pubmed: 15817564
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Vector Borne Zoonotic Dis. 2012 Apr;12(4):310-20
pubmed: 22217181
Clin Infect Dis. 2019 Mar 5;68(6):919-926
pubmed: 30184178
J Clin Microbiol. 2005 Feb;43(2):696-702
pubmed: 15695666
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2311
pubmed: 23875046
Emerg Infect Dis. 2016 Nov;22(11):2000-2002
pubmed: 27767924
J Med Entomol. 2005 Sep;42(5):891-8
pubmed: 16366001
Am J Trop Med Hyg. 2015 Apr;92(4):752-757
pubmed: 25732684
PLoS One. 2018 May 10;13(5):e0196857
pubmed: 29746539
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239
J Virol. 2010 Jan;84(2):1014-25
pubmed: 19889755
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397

Auteurs

John A Lednicky (JA)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States of America.

Sarah K White (SK)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States of America.

Carla N Mavian (CN)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, United States of America.

Maha A El Badry (MA)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States of America.

Taina Telisma (T)

Christianville Foundation School Clinic, Gressier, Haiti.

Marco Salemi (M)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, United States of America.

Bernard A OKech (BA)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States of America.

V Madsen Beau De Rochars (VM)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Health Services Research, Management, and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States of America.

J Glenn Morris (JG)

Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States of America.
Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, United States of America.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH